Table 2.
Biochemical analysis (LPO, GSH, CAT and SOD)
Group | LPO (nmol MDA/g tissue) | GSH (μg/mg tissue) | CAT (U/μg protein) | SOD (U/mg protein) |
---|---|---|---|---|
I | 1.65 ± 0.10 | 0.84 ± 0.05a | 1.97 ± 0.13b | 4.93 ± 0.42 |
II | 1.82 ± 0.09b | 0.61 ± 0.06b | 2.33 ± 0.14b | 4.47 ± 0.41 |
III | 1.30 ± 0.23a | 0.95 ± 0.07a | 0.81 ± 0.06a | 4.98 ± 0.39 |
IV | 1.37 ± 0.16a | 0.77 ± 0.09 | 1.67 ± 0.33a,b | 5.35 ± 0.45 |
V | 1.48 ± 0.19 | 0.89 ± 0.09a | 0.83 ± 0.07a | 5.82 ± 0.38 |
VI | 2.26 ± 0.19a,b | 0.95 ± 0.07a | 0.95 ± 0.06a | 4.78 ± 0.25 |
VII | 1.35 ± 0.16 | 0.75 ± 0.10 | 0.86 ± 0.10a | 4.71 ± 0.50 |
VIII | 1.76 ± 0.13 | 0.66 ± 0.11b | 0.64 ± 0.06a | 4.49 ± 0.43 |
IX | 2.14 ± 0.17b | 0.45 ± 0.07b | 0.84 ± 0.07a | 5.84 ± 0.58 |
a P < 0.05 compared with carcinogen control; b P < 0.05 compared with curcumin